Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
Por um escritor misterioso
Descrição
Directing the Metabolism of Drugs Away from CYP450: The Use of Oxetane Rings
One-Pot 1,1-Dihydrofluoroalkylation of Amines Using Sulfuryl Fluoride
Sophie GONG, Sr. scientist, GlaxoSmithKline, London, GSK, R&D China
Kelly Dong's research works China FAW Group Corpration R&D Center, Jilin and other places
PDF) S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models
CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis - ScienceDirect
One-Pot 1,1-Dihydrofluoroalkylation of Amines Using Sulfuryl Fluoride
Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeutics - ScienceDirect
Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
Discovery of Novel 1-Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
Chan–Lam Reaction and Lewis Acid Promoted 1,3-Rearrangement of N–O Bonds to Prepare N-(2-Hydroxyaryl)pyridin-2-ones
de
por adulto (o preço varia de acordo com o tamanho do grupo)